Three-way merger regenerates new company
Article Abstract:
Biotechnology companies Hopkinton, MA-based Creative BioMolecules, and Cambridge, MA-based Reprogenesis and Ontogeny have announced that they will merge. The new company will be much greater than the sum of the parts because of the scope of each company's drug development program.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Three-way merger regenerates new company
Article Abstract:
Creative BioMolecules (Hopkinton, MA), Ontogeny (Cambridge, MA), and Reprogenesis (Cambridge, MA) have joined together to form Curis, which plans to be a leader in regenerative medicine.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Chiron buys PathoGenesis
Article Abstract:
Emeryville, CA-based Chiron has agreed to acquire Seattle, WA-based PathoGenesis in a $700 million all cash deal.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Low-end digital cameras: what's selling and why. CVS photo division puts customers first. Kids go digital
- Abstracts: The sun rises in the east. Lessons in self-awareness. Risk analysis
- Abstracts: The sun rises in the east. Dining out. One for all?
- Abstracts: On advertising: your newspaper isn't a riddle. The marriage business. Learning from media heavyweights
- Abstracts: Gene pill patents a surprise for gene therapy. US FDA approves new class of HIV therapeutics. First round to Amgen in EPO battle